The company has not filed an annual or quarterly report since its FY2016 20-F, filed Mar 23, 2017. Its latest SEC filing is a SC 13D/A from Aug 1, 2017.
20-F for FY2016, filed Mar 23, 2017
The sections below describe the company as of the FY2016 annual report.
Sells professional aesthetic medical devices and related consumables to physicians and other qualified practitioners.
20-F for FY2016, filed Mar 23, 2017
Physicians and other qualified practitioners, plus aestheticians and medical spas, are the main buyers. Syneron sells directly through subsidiaries in some countries and through distributors in other markets.
20-F for FY2016, filed Mar 23, 2017
Home-use business
The older report included home-use devices in its Emerging Business Unit; the later report says Syneron transferred its home-use businesses to a joint venture and describes its operating business as professional aesthetic equipment.
20-F for FY2013, filed Mar 19, 2014 20-F for FY2016, filed Mar 23, 2017In order to provide increased transparency to our financial results, historically we broke out our financial results into two segments –…View ↗
Recurring sales
The older report describes equipment that users can upgrade with hand pieces and software; the later report adds devices with disposable components or per-treatment charges as part of a move toward recurring sales.
20-F for FY2013, filed Mar 19, 2014 20-F for FY2016, filed Mar 23, 2017Our Syneron devices generally consist of one or more hand pieces and a console that incorporates multiple energy sources, sophisticated…View ↗
A number of products that we launched since the middle of 2013 are designed to support the Company's strategy to move toward a business…View ↗
Competes with Cutera, Cynosure, Hologic, Lumenis, Zeltiq Aesthetics, Allergan, Sciton, Alma Lasers, Lutronic, Valeant Pharmaceuticals International, and Merz Pharma Group
20-F for FY2016, filed Mar 23, 2017Although we are a global leader in the medical aesthetic device market, our industry is subject to intense competition and technological…View ↗
Loading...
